Lisata Therapeutics Shares Fall After Terminating Kuva Labs Deal

MT Newswires Live

07/25

Lisata Therapeutics (LSTA) shares were down about 17% in Friday afternoon trading after the company said it has terminated its previously announced proposed merger with Kuva Labs.

Lisata was informed that Kuva Labs failed to secure sufficient funding to fulfill the tender offer to acquire all of Lisata's outstanding shares, the company said in a Friday filing.

As a result of the termination, Lisata said it is entitled to a fee of $2 million and has the right to seek damages, but there is no assurance it will be able to obtain damages due to its limited funds for litigation and Kuva Labs' inability to satisfy its claims with its existing assets.

Price: 1.77, Change: -0.35, Percent Change: -16.51

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2654031755"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2654031755\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2654031755?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-25 02:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2654031755","market":"sh","top_or_hot":-1,"title":"Lisata Therapeutics Shares Fall After Terminating Kuva Labs Deal","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/LSTA\">Lisata Therapeutics</a> (LSTA) shares were down about 17% in Friday afternoon trading after the company said it has terminated its previously announced proposed merger with Kuva Labs.</p><p>Lisata was informed that Kuva Labs failed to secure sufficient funding to fulfill the tender offer to acquire all of Lisata's outstanding shares, the company said in a Friday filing.</p><p>As a result of the termination, Lisata said it is entitled to a fee of $2 million and has the right to seek damages, but there is no assurance it will be able to obtain damages due to its limited funds for litigation and Kuva Labs' inability to satisfy its claims with its existing assets.</p><p>Price: 1.77, Change: -0.35, Percent Change: -16.51</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lisata Therapeutics Shares Fall After Terminating Kuva Labs Deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLisata Therapeutics Shares Fall After Terminating Kuva Labs Deal\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-07-25 02:59</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/LSTA\">Lisata Therapeutics</a> (LSTA) shares were down about 17% in Friday afternoon trading after the company said it has terminated its previously announced proposed merger with Kuva Labs.</p><p>Lisata was informed that Kuva Labs failed to secure sufficient funding to fulfill the tender offer to acquire all of Lisata's outstanding shares, the company said in a Friday filing.</p><p>As a result of the termination, Lisata said it is entitled to a fee of $2 million and has the right to seek damages, but there is no assurance it will be able to obtain damages due to its limited funds for litigation and Kuva Labs' inability to satisfy its claims with its existing assets.</p><p>Price: 1.77, Change: -0.35, Percent Change: -16.51</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"半新股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2654031755","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2654031755","pubTimestamp":1784919576,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Lisata Therapeutics  shares were down about 17% in Friday afternoon trading after the company said it has terminated its previously announced proposed merger with Kuva Labs.Lisata was informed that Kuva Labs failed to secure sufficient funding to fulfill the tender offer to acquire all of Lisata's outstanding shares, the company said in a Friday filing.As a result of the termination, Lisata said it is entitled to a fee of $2 million and has the right to seek damages, but there is no assurance it will be able to obtain damages due to its limited funds for litigation and Kuva Labs' inability to satisfy its claims with its existing assets.Price: 1.77, Change: -0.35, Percent Change: -16.51","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","LENZ":"Therapeutics","BK4139":"生物科技","LSTA":"LISATA THERAPEUTICS INC","BK4007":"制药"},"translate_title":"Lisata Therapeutics 终止 Kuva Labs 交易后股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LSTA":1,"LENZ":1.5},"content_text":"Lisata Therapeutics (LSTA) shares were down about 17% in Friday afternoon trading after the company said it has terminated its previously announced proposed merger with Kuva Labs.Lisata was informed that Kuva Labs failed to secure sufficient funding to fulfill the tender offer to acquire all of Lisata's outstanding shares, the company said in a Friday filing.As a result of the termination, Lisata said it is entitled to a fee of $2 million and has the right to seek damages, but there is no assurance it will be able to obtain damages due to its limited funds for litigation and Kuva Labs' inability to satisfy its claims with its existing assets.Price: 1.77, Change: -0.35, Percent Change: -16.51","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}